121 related articles for article (PubMed ID: 1420094)
1. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group.
Cambillau M; Simon A; Amar J; Giral P; Atger V; Segond P; Levenson J; Merli I; Megnien JL; Plainfosse MC
Arterioscler Thromb; 1992 Nov; 12(11):1346-52. PubMed ID: 1420094
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients.
Baldassarre D; Tremoli E; Franceschini G; Michelagnoli S; Sirtori CR
Stroke; 1996 Jun; 27(6):1044-9. PubMed ID: 8650712
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prévention Cardio-vasculaire en Médecine du Travail METRA Group.
Giral P; Pithois-Merli I; Filitti V; Levenson J; Plainfosse MC; Mainardi C; Simon AC
Arch Intern Med; 1991 May; 151(5):950-6. PubMed ID: 2025143
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein subfractions as markers of early atherosclerosis. PCVMETRA Group. Prévention Cardio-Vasculaire en Medecene du Travail.
Atger V; Giral P; Simon A; Cambillau M; Levenson J; Gariepy J; Megnien JL; Moatti N
Am J Cardiol; 1995 Jan; 75(2):127-31. PubMed ID: 7810486
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. PCVMETRA Group.
Chappey B; Myara I; Giral P; Kerharo G; Plainfosse MC; Levenson J; Simon A; Moatti N
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):334-9. PubMed ID: 7749843
[TBL] [Abstract][Full Text] [Related]
6. Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group.
Megnien JL; Sene V; Jeannin S; Hernigou A; Plainfosse MC; Merli I; Atger V; Moatti N; Levenson J; Simon A
Circulation; 1992 May; 85(5):1799-807. PubMed ID: 1572036
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
[TBL] [Abstract][Full Text] [Related]
8. Association of serum lipoprotein(a) with ultrasonographically determined early atherosclerotic changes in the carotid and femoral arteries in kidney transplanted patients.
Nasri H; Baradaran A
Transplant Proc; 2004 Nov; 36(9):2683-6. PubMed ID: 15621123
[TBL] [Abstract][Full Text] [Related]
9. [Clinical findings of arteriosclerosis and serum lipoprotein(a) concentration in elderly patients].
Iwamoto T; Ami M; Shimizu T; Tanaka Y; Nishimura T; Takasaki M
Nihon Ronen Igakkai Zasshi; 2000 Oct; 37(10):811-8. PubMed ID: 11215222
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study.
Willeit J; Kiechl S; Santer P; Oberhollenzer F; Egger G; Jarosch E; Mair A
Stroke; 1995 Sep; 26(9):1582-7. PubMed ID: 7660402
[TBL] [Abstract][Full Text] [Related]
11. Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia.
Tatò F; Keller C; Schuster H; Spengel F; Wolfram G; Zöllner N
Atherosclerosis; 1993 Jun; 101(1):69-77. PubMed ID: 8216504
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.
Bos S; Duvekot MH; Touw-Blommesteijn AC; Verhoeven AJ; Mulder MT; Watts GF; Sijbrands EJ; Roeters van Lennep JE
Atherosclerosis; 2015 Sep; 242(1):226-9. PubMed ID: 26222903
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study.
Aasvee K; Kurvinen E; Jordania R; Jauhiainen M; Sundvall J
Scand J Clin Lab Invest; 2004; 64(3):245-53. PubMed ID: 15222635
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular disease and Lp(a): its role in atherosclerotic plaque formation and vessel wall elasticity of the carotid arteries.
Jürgens G; Költringer P
Chem Phys Lipids; 1994 Jan; 67-68():429-34. PubMed ID: 8187243
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein Lp(a) and cerebrovascular disease in the elderly: correlations with the severity of extracranial carotid atherosclerosis assessed by ultrasonography.
Denti L; Marchini L; Pasolini G; Baffoni MT; Ablondi F; Valenti G
Acta Biomed Ateneo Parmense; 1995; 66(3-4):175-83. PubMed ID: 8578935
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery.
Srámek A; Reiber JH; Baak-Pablo R; Sturk A; Rosendaal FR
J Thromb Haemost; 2003 Feb; 1(2):374-9. PubMed ID: 12871513
[TBL] [Abstract][Full Text] [Related]
17. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
[TBL] [Abstract][Full Text] [Related]
18. Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels.
Barth JA; Deckelbaum RJ; Starc TJ; Shea S; Mosca L; Berglund L
J Lab Clin Med; 1999 Mar; 133(3):237-44. PubMed ID: 10072255
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.
Watts GF; Kearney EM; Taub NA; Slavin BM
J Clin Pathol; 1993 Mar; 46(3):267-70. PubMed ID: 8463422
[TBL] [Abstract][Full Text] [Related]
20. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.
Desai NR; Kohli P; Giugliano RP; O'Donoghue ML; Somaratne R; Zhou J; Hoffman EB; Huang F; Rogers WJ; Wasserman SM; Scott R; Sabatine MS
Circulation; 2013 Aug; 128(9):962-9. PubMed ID: 23884353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
